Upperton Pharma Solutions Announces £15m Investment in New FacilitiesGemma Cann2022-06-30T11:25:49+01:00May 23rd, 2022|BioCity Nottingham, News|
Reach Separations Marks 10th Birthday Milestone with Further Expansion into EuropeGemma Cann2022-07-28T15:48:05+01:00May 17th, 2022|BioCity Nottingham, News|
Absolute Antibody to be Featured on “World’s Greatest!…” Television SeriesGemma Cann2022-06-30T11:27:06+01:00May 17th, 2022|News, Wilton Centre|
Amphista Therapeutics Enters Strategic Collaboration with Bristol Myers SquibbGemma Cann2022-06-30T11:27:54+01:00May 4th, 2022|BioCity Glasgow, Investment, News|
Choosing to Challenge Access to Healthcare: I.W.D Interview with Anna MaxwellGemma Cann2022-06-30T11:50:16+01:00November 19th, 2021|Article|
Biotech Spinout Case Study: Kinomica – From Seed to Oversubscribed £3.9m Series A.Gemma Cann2023-09-04T12:56:26+01:00November 19th, 2021|Accelerator, Article|
Two Years Later: We Catch Up with Alex Birks, CEO of Med-Tech Start-Up Suji BFRGemma Cann2022-06-30T11:51:31+01:00November 19th, 2021|Accelerator, Article|
NanoSyrinx Announces Oversubscribed £6.2m Seed Funding RoundGemma Cann2022-06-30T12:01:24+01:00July 19th, 2021|Investment, News|
Maxwellia’s Lovima Contraceptive Pill Granted MHRA LicenceGemma Cann2022-06-30T12:01:39+01:00July 14th, 2021|News|
Rinri Therapeutics Secures £3.2m Innovate UK FundingGemma Cann2023-09-04T13:12:37+01:00May 13th, 2021|Investment, News|
